V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009818 | 310005242 | 1.5 | 49.8 | null | 2016-07-06 | 2016-12-23 | CARBOPLATIN + FLUOROURACIL | N | N | 310024459 | SUNITINIB |
| 310009819 | 310005243 | null | null | null | 2014-09-16 | 2015-01-03 | RUXOLITINIB | N | N | 310024498 | TRABECTEDIN |
| 310009820 | 310008304 | 1.57 | 53 | Curative (C) | 2016-01-19 | 2016-01-20 | Niraparib | N | N | 310024524 | INTERFERON |
| 310009821 | 310005247 | 1.64 | 70.2 | Palliative (P) | 2016-05-14 | 2016-05-15 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 310024532 | ALEMTUZUMAB |
| 310009822 | 310005249 | 1.75 | 107 | Palliative (P) | 2014-07-05 | 2014-07-08 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | N | N | 310024541 | ATEZOLIZUMAB |
| 310009823 | 310005249 | 1.65 | 73.7 | Palliative (P) | 2017-09-16 | 2017-09-17 | Capecitabine | N | N | 310024541 | DOXORUBICIN + OLARATUMAB |
| 310009824 | 310005253 | 1.55 | 151.6 | null | 2014-11-23 | 2014-11-23 | LANREOTIDE | 02 | N | 310024543 | CAPECITABINE + CISPLATIN |
| 310009825 | 310005259 | 1.56 | 48.5 | Curative (C) | 2017-05-08 | 2017-05-09 | Capecitabine + Cisplatin | 02 | N | 310024586 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310009826 | 310005260 | 1.84 | null | Palliative (P) | 2017-10-09 | 2017-11-06 | CVP | N | N | 310024602 | METHOTREXATE |
| 310009827 | 310008311 | 1.65 | 63.9 | Not known (9) | 2018-12-17 | 2018-12-20 | Capecitabine + Oxaliplatin 21day | N | N | 310024631 | SUNITINIB |
| 310009828 | 310005261 | null | 59.8 | Palliative (P) | 2018-05-11 | 2018-10-19 | Capecitabine | 2 | Y | 310024633 | FLUOROURACIL + RT |
| 310009829 | 310005269 | 1.64 | null | Curative (C) | 2014-07-07 | 2014-10-01 | Azacitidine | N | N | 310024669 | INTERFERON |
| 310009830 | 310011844 | null | null | Palliative (P) | 2016-06-10 | 2016-06-15 | VINCRISTINE | 02 | null | 310024800 | RMS 2005 TRIAL |
| 310009831 | 310005271 | 1.6 | 79.2 | Curative (C) | 2017-12-25 | 2018-02-18 | Methotrexate High Dose (3g/m2) | 2 | N | 310024801 | CYTARABINE HD + METHOTREXATE HD |
| 310009832 | 310009938 | null | null | Disease modification (D) | 2016-05-14 | 2016-06-04 | Azacitidine | null | null | 310024826 | MVAC |
| 310009833 | 310005275 | null | 49 | Adjuvant (A) | 2017-08-30 | 2018-02-05 | BEAM + FLUDARABINE | Y | N | 310024828 | ECX |
| 310009834 | 310005278 | 1.76 | 82.3 | Palliative (P) | 2017-07-06 | 2017-11-28 | NIVOLUMAB | 2 | N | 310024839 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310009835 | 310005282 | 1.7 | 62.2 | Disease modification (D) | 2018-06-01 | 2018-06-01 | FLUOROURACIL + IRINOTECAN | 02 | N | 310024848 | METHOTREXATE HIGH DOSE |
| 310009836 | 310008322 | 1.64 | 79.6 | Curative (C) | 2015-09-22 | 2016-01-31 | TIP | N | N | 310024859 | EP |
| 310009837 | 310008323 | 1.59 | 69.7 | Curative (C) | 2016-01-29 | 2016-02-03 | ICE | 02 | N | 310024862 | TRASTUZUMAB |
| 310009838 | 310008324 | 1.72 | 52.3 | Curative (C) | 2015-01-30 | 2015-02-08 | Trabectedin | 02 | N | 310024907 | GEMCITABINE + OXALIPLATIN |
| 310009839 | 310005290 | null | 0 | Palliative (P) | 2017-04-10 | 2017-04-11 | Sunitinib | N | N | 310024932 | INTERFERON |
| 310009840 | 310005290 | 1.82 | 65.3 | Neo-adjuvant (N) | 2015-04-22 | 2015-04-23 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | null | 310024932 | FLUOROURACIL + MITOMYCIN + RT |
| 310009841 | 310010815 | 1.84 | 80 | null | 2014-01-12 | 2014-01-19 | IVE-R | 02 | N | 310024934 | CYTARABINE HD + METHOTREXATE HD |
| 310009842 | 310011317 | 1.64 | 103 | Curative (C) | 2016-08-16 | 2016-08-21 | Trastuzumab Subcutaneous | N | N | 310024938 | IRINOTECAN + MDG |
| 310009843 | 310011317 | 1.85 | 14.3 | Palliative (P) | 2017-07-13 | 2017-10-08 | Cetuximab 7 day (>Cycle 2) | Y | null | 310024938 | THALIDOMIDE |
| 310009844 | 310009947 | 1.63 | 56.1 | null | 2016-07-14 | 2016-07-18 | VINCRISTINE | N | N | 310024973 | CYTARABINE INTRATHECAL |
| 310009845 | 310005299 | 1.66 | 83 | Curative (C) | 2017-06-27 | 2017-06-27 | Gemcitabine + Oxaliplatin | 02 | N | 310024987 | PREDNISOLONE + VINBLASTINE + RITUXIMAB |
| 310009846 | 310005301 | 1.75 | 63 | Curative (C) | 2015-09-29 | 2015-10-28 | Capecitabine + Oxaliplatin 21day | 02 | N | 310024988 | CAV |
| 310009848 | 310005305 | 1.86 | 65.05 | Palliative (P) | 2017-06-18 | 2017-06-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 310025017 | EOX |
| 310009849 | 310008335 | null | null | Palliative (P) | 2015-06-28 | 2015-06-28 | PEG INTERFERON | 02 | N | 310025049 | INTERFERON |
| 310009850 | 310005309 | null | 65.5 | Neo-adjuvant (N) | 2018-05-22 | 2018-05-31 | PCV | N | N | 310025087 | IBRUTINIB |
| 310009851 | 310005314 | 1.76 | 63 | Palliative (P) | null | 2013-08-16 | PEG INTERFERON | null | N | 310025127 | CARBOPLATIN + DOCETAXEL |
| 310009853 | 310005317 | 1.59 | 101.2 | Adjuvant (A) | 2017-01-28 | 2017-01-31 | Bendamustine + prednisolone | N | N | 310025179 | CARBOPLATIN + DOCETAXEL |
| 310009854 | 310005318 | 1.72 | null | Palliative (P) | 2017-11-20 | 2017-11-22 | ICON8 TRIAL | 02 | N | 310025187 | OXALIPLATIN + MDG |
| 310009855 | 310005319 | 1.4 | 65 | Adjuvant (A) | 2015-08-26 | 2015-09-02 | CAPECITABINE + OXALIPLATIN | N | N | 310025194 | CISPLATIN + ETOPOSIDE |
| 310009856 | 310005322 | 1.67 | 52.8 | Palliative (P) | 2016-12-27 | 2017-01-10 | Trabectedin | 2 | N | 310025199 | TEMOZOLOMIDE |
| 310009857 | 310005324 | 1.7 | 70.1 | Palliative (P) | 2017-05-15 | 2017-05-28 | TRASTUZUMAB | N | N | 310025212 | TOPOTECAN |
| 310009858 | 310005324 | 1.79 | 88.1 | Palliative (P) | 2016-10-27 | 2016-11-25 | Methotrexate High Dose (3g/m2) | N | N | 310025212 | CEV |
| 310009859 | 310008344 | 1.5 | 67.1 | Palliative (P) | 2015-06-27 | 2015-07-20 | Bendamustine +/- Prednisolone | 2 | N | 310025231 | MITOMYCIN |
| 310009860 | 310008344 | 1.71 | 59.2 | Curative (C) | 2015-09-22 | 2015-09-28 | LENALIDOMIDE | 2 | N | 310025231 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 310009861 | 310005326 | 1.68 | null | Palliative (P) | 2013-10-25 | 2013-10-25 | METHOTREXATE | 2 | N | 310025252 | INTERFERON |
| 310009862 | 310005334 | 1.63 | 40.1 | Palliative (P) | 2014-01-21 | 2014-01-23 | Cisplatin + Etoposide (3 day) | N | N | 310025319 | EPOC TRIAL |
| 310009863 | 310005335 | 1.64 | null | null | 2013-05-04 | 2013-07-09 | Azacitidine | N | N | 310025333 | OXALIPLATIN + MDG |
| 310009864 | 310005336 | 1.82 | 78.4 | Palliative (P) | 2015-10-05 | 2015-10-08 | CETUXIMAB | 2 | N | 310025341 | ATEZOLIZUMAB |
| 310009865 | 310009957 | 1.57 | 71.2 | Palliative (P) | 2015-06-03 | 2015-06-09 | Topotecan IV 7 day | 02 | N | 310025352 | SUNITINIB |
| 310009866 | 310005343 | 1.82 | null | Palliative (P) | 2018-04-17 | 2018-05-21 | CETUXIMAB | N | N | 310025360 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 310009867 | 310005343 | 0 | null | Adjuvant (A) | 2016-05-04 | 2016-08-22 | ICON8 TRIAL | N | N | 310025360 | FEC |
| 310009868 | 310005345 | 1.68 | 6.82 | Adjuvant (A) | 2019-01-29 | 2019-01-31 | GEFITINIB | N | N | 310025385 | CHOEP |
| 310009869 | 310008351 | null | 0 | null | 2013-12-12 | 2014-06-17 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | 02 | null | 310025395 | CTD |